Impact of COVID-19 on gynecologic oncology patients: an SGO COVID-19 and Gynecologic Cancer Registry study (050)

Objectives: The COVID-19 pandemic has disrupted timely medical care, including receipt of anticancer therapy. Gynecologic oncology (GO) patients (pts), who are often comorbid and require a range of therapies, may have varied responses to COVID-19 infection. Our study aimed to describe outcomes for G...

Descripción completa

Detalles Bibliográficos
Autores principales: Glaser, Gretchen, Lara, Olivia, Pothuri, Bhavana, Grimaldi, Carolina Gomez, Prescott, Lauren, Mastroyannis, Spyridon, Kim, Sarah, ElNaggar, Adam, Torres, Diogo, Conrad, Lesley, McGree, Michaela, Weaver, Amy, Huh, Warner, Cohn, David, Fader, Amanda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2022
Materias:
Focused Plenary III: Inequities During the Pandemic and Beyond
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9462874/
http://dx.doi.org/10.1016/S0090-8258(22)01269-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9462874/
http://dx.doi.org/10.1016/S0090-8258(22)01269-0

Ejemplares similares